Ritlecitinib is a small molecule, being developed by Pfizer, for the oral treatment of ulcerative colitis, alopecia areata, vitiligo, and Crohn's disease. Reference standards of Ritlecitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ritlecitinib
Catalogue No.:PA 18 1470000
CAS :
Molecular Formula : C15H19N5O
Molecular Weight : 285.35
Benzyl (2S,5S)-5-amino-2-methylpiperidine-1-carboxylate
Catalogue No.:PA 18 1471000
Molecular Formula : C14H20N2O2
Molecular Weight : 248.33
Benzyl (2R,5S)-5-amino-2-methylpiperidine-1-carboxylate
Catalogue No.:PA 18 1471001
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
